Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study.
Journal: Journal for immunotherapy of cancer
Published: September 26, 2022
Response to: Factors Associated With COVID-19 Breakthrough Infections: Correspondence.
Journal: Journal of occupational and environmental medicine
Published: July 28, 2022
Factors Associated With COVID-19 Breakthrough Infections in Large Midwestern Healthcare System: Implications for Vulnerable Healthcare Personnel.
Journal: Journal of occupational and environmental medicine
Published: June 08, 2022
Incidence of COVID-19 reinfection among Midwestern healthcare employees.
Journal: PloS one
Published: August 19, 2021
Disparities in Seroprevalence of SARS-CoV-2 Immunoglobulin Antibodies in a Large Midwestern Health Care System.
Journal: Public health reports (Washington, D.C. : 1974)
Published: March 06, 2021
Reducing Unwarranted Oncology Care Variation Across a Clinically Integrated Network: A Collaborative Physician Engagement Strategy.
Journal: Journal of oncology practice
Published: October 02, 2019
Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 04, 2019
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0.
Journal: Journal for immunotherapy of cancer
Published: January 12, 2018
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
Journal: The New England journal of medicine
Published: October 09, 2016
Sequencing of New and Old Therapies for Metastatic Melanoma.
Journal: Current treatment options in oncology
Published: August 13, 2016
High-Dose Radiation as a Dramatic, Immunological Primer in Locally Advanced Melanoma.
Journal: Cureus
Published: February 06, 2016
Last Updated: 09/26/2026